| CAS NO: | 1096708-71-2 |
| 生物活性 | Tovorafenib (TAK-580, MLN 2480) is an orally active and selective inhibitor ofpan-Rafkinase. | ||||||||||||||||
| IC50& Target[1] |
| ||||||||||||||||
| 体外研究 (In Vitro) | Tovorafenib (TAK-580, MLN 2480) has effect on reversing feedback activation of MEK in response to TAK-733, leading to more concerted MAPK pathway inhibition[1]. | ||||||||||||||||
| 体内研究 (In Vivo) | Tovorafenib (TAK-580, MLN 2480) inhibits MAPK pathway signaling in BRAF mutant and some RAS mutant preclinical cancer models at concentrations that are tolerated in vivo. TAK-580 (MLN 2480) is most potent in BRAF mutant melanoma models but also has single agent activity in some RAS mutant models. The combination of MLN2480 with TAK-733 inhibits the growth of a broader range of RAS mutant tumor models than single agent TAK-580 (MLN 2480), including primary human tumor xenograft models of melanoma and CRC[1]. | ||||||||||||||||
| Clinical Trial | |||||||||||||||||
| 分子量 | 506.29 | ||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| Formula | C17H12Cl2F3N7O2S | ||||||||||||||||
| CAS 号 | 1096708-71-2 | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 |
| ||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : 50 mg/mL(98.76 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
| 维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2026 |
